ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Brompheniramine Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-5F8340
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Brompheniramine Market Insights Forecast to 2028
BUY CHAPTERS

Global Brompheniramine Market Research Report 2025

Code: QYRE-Auto-5F8340
Report
July 2025
Pages:90
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Pfizer Inc
AMAG Pharmaceuticals
Pai
USL Pharma
Watson Laboratories
TEVA
Ivax Pharmaceuticals
Newtron Pharmaceuticals
Nexgen Pharma
Endo International
Novartis
Eon Pharma
Merck
Tanta Pharmaceuticals

Brompheniramine Market Size

The global market for Brompheniramine was valued at US$ 591 million in the year 2024 and is projected to reach a revised size of US$ 801 million by 2031, growing at a CAGR of 4.5% during the forecast period.

Brompheniramine Market

Brompheniramine Market

Brompheniramine, is an antihistamine drug of the propylamine (alkylamine) class. It is readily available over the counter and is indicated for the treatment of the symptoms of the common cold and allergic rhinitis, such as runny nose, itchy eyes, watery eyes, and sneezing. It is a first-generation antihistamine and one of the drugs of highest anticholinergic activity
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Brompheniramine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Brompheniramine.
The Brompheniramine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Brompheniramine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Brompheniramine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Brompheniramine Market Report

Report Metric Details
Report Name Brompheniramine Market
Accounted market size in year US$ 591 million
Forecasted market size in 2031 US$ 801 million
CAGR 4.5%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Oral Solution
  • Tablet
Segment by Application
  • Hospital
  • Drug Store
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Pfizer, AMAG Pharmaceuticals, PAI, USL Pharma, Watson Laboratories, Teva, Ivax Pharmaceuticals, Newtron Pharmaceuticals, Nexgen Pharma, Endo International, Novartis, Eon Pharma, Merck, Tanta Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Brompheniramine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Brompheniramine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Brompheniramine Market growing?

Ans: The Brompheniramine Market witnessing a CAGR of 4.5% during the forecast period 2025-2031.

What is the Brompheniramine Market size in 2031?

Ans: The Brompheniramine Market size in 2031 will be US$ 801 million.

Who are the main players in the Brompheniramine Market report?

Ans: The main players in the Brompheniramine Market are Pfizer, AMAG Pharmaceuticals, PAI, USL Pharma, Watson Laboratories, Teva, Ivax Pharmaceuticals, Newtron Pharmaceuticals, Nexgen Pharma, Endo International, Novartis, Eon Pharma, Merck, Tanta Pharmaceuticals

What are the Application segmentation covered in the Brompheniramine Market report?

Ans: The Applications covered in the Brompheniramine Market report are Hospital, Drug Store

What are the Type segmentation covered in the Brompheniramine Market report?

Ans: The Types covered in the Brompheniramine Market report are Oral Solution, Tablet

Recommended Reports

Allergy Treatment Drugs

Respiratory & Rhinitis

Antiallergics & OTC

1 Brompheniramine Market Overview
1.1 Product Definition
1.2 Brompheniramine by Type
1.2.1 Global Brompheniramine Market Value Comparison by Type (2024 VS 2031)
1.2.2 Oral Solution
1.2.3 Tablet
1.3 Brompheniramine by Application
1.3.1 Global Brompheniramine Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Drug Store
1.4 Global Brompheniramine Market Size Estimates and Forecasts
1.4.1 Global Brompheniramine Revenue 2020-2031
1.4.2 Global Brompheniramine Sales 2020-2031
1.4.3 Global Brompheniramine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Brompheniramine Market Competition by Manufacturers
2.1 Global Brompheniramine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Brompheniramine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Brompheniramine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Brompheniramine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Brompheniramine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Brompheniramine, Product Type & Application
2.7 Global Key Manufacturers of Brompheniramine, Date of Enter into This Industry
2.8 Global Brompheniramine Market Competitive Situation and Trends
2.8.1 Global Brompheniramine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Brompheniramine Players Market Share by Revenue
2.8.3 Global Brompheniramine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Brompheniramine Market Scenario by Region
3.1 Global Brompheniramine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Brompheniramine Sales by Region: 2020-2031
3.2.1 Global Brompheniramine Sales by Region: 2020-2025
3.2.2 Global Brompheniramine Sales by Region: 2026-2031
3.3 Global Brompheniramine Revenue by Region: 2020-2031
3.3.1 Global Brompheniramine Revenue by Region: 2020-2025
3.3.2 Global Brompheniramine Revenue by Region: 2026-2031
3.4 North America Brompheniramine Market Facts & Figures by Country
3.4.1 North America Brompheniramine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Brompheniramine Sales by Country (2020-2031)
3.4.3 North America Brompheniramine Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Brompheniramine Market Facts & Figures by Country
3.5.1 Europe Brompheniramine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Brompheniramine Sales by Country (2020-2031)
3.5.3 Europe Brompheniramine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Brompheniramine Market Facts & Figures by Region
3.6.1 Asia Pacific Brompheniramine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Brompheniramine Sales by Region (2020-2031)
3.6.3 Asia Pacific Brompheniramine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Brompheniramine Market Facts & Figures by Country
3.7.1 Latin America Brompheniramine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Brompheniramine Sales by Country (2020-2031)
3.7.3 Latin America Brompheniramine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Brompheniramine Market Facts & Figures by Country
3.8.1 Middle East and Africa Brompheniramine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Brompheniramine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Brompheniramine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Brompheniramine Sales by Type (2020-2031)
4.1.1 Global Brompheniramine Sales by Type (2020-2025)
4.1.2 Global Brompheniramine Sales by Type (2026-2031)
4.1.3 Global Brompheniramine Sales Market Share by Type (2020-2031)
4.2 Global Brompheniramine Revenue by Type (2020-2031)
4.2.1 Global Brompheniramine Revenue by Type (2020-2025)
4.2.2 Global Brompheniramine Revenue by Type (2026-2031)
4.2.3 Global Brompheniramine Revenue Market Share by Type (2020-2031)
4.3 Global Brompheniramine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Brompheniramine Sales by Application (2020-2031)
5.1.1 Global Brompheniramine Sales by Application (2020-2025)
5.1.2 Global Brompheniramine Sales by Application (2026-2031)
5.1.3 Global Brompheniramine Sales Market Share by Application (2020-2031)
5.2 Global Brompheniramine Revenue by Application (2020-2031)
5.2.1 Global Brompheniramine Revenue by Application (2020-2025)
5.2.2 Global Brompheniramine Revenue by Application (2026-2031)
5.2.3 Global Brompheniramine Revenue Market Share by Application (2020-2031)
5.3 Global Brompheniramine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Brompheniramine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Pfizer Brompheniramine Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 AMAG Pharmaceuticals
6.2.1 AMAG Pharmaceuticals Company Information
6.2.2 AMAG Pharmaceuticals Description and Business Overview
6.2.3 AMAG Pharmaceuticals Brompheniramine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 AMAG Pharmaceuticals Brompheniramine Product Portfolio
6.2.5 AMAG Pharmaceuticals Recent Developments/Updates
6.3 PAI
6.3.1 PAI Company Information
6.3.2 PAI Description and Business Overview
6.3.3 PAI Brompheniramine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 PAI Brompheniramine Product Portfolio
6.3.5 PAI Recent Developments/Updates
6.4 USL Pharma
6.4.1 USL Pharma Company Information
6.4.2 USL Pharma Description and Business Overview
6.4.3 USL Pharma Brompheniramine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 USL Pharma Brompheniramine Product Portfolio
6.4.5 USL Pharma Recent Developments/Updates
6.5 Watson Laboratories
6.5.1 Watson Laboratories Company Information
6.5.2 Watson Laboratories Description and Business Overview
6.5.3 Watson Laboratories Brompheniramine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Watson Laboratories Brompheniramine Product Portfolio
6.5.5 Watson Laboratories Recent Developments/Updates
6.6 Teva
6.6.1 Teva Company Information
6.6.2 Teva Description and Business Overview
6.6.3 Teva Brompheniramine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Teva Brompheniramine Product Portfolio
6.6.5 Teva Recent Developments/Updates
6.7 Ivax Pharmaceuticals
6.7.1 Ivax Pharmaceuticals Company Information
6.7.2 Ivax Pharmaceuticals Description and Business Overview
6.7.3 Ivax Pharmaceuticals Brompheniramine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Ivax Pharmaceuticals Brompheniramine Product Portfolio
6.7.5 Ivax Pharmaceuticals Recent Developments/Updates
6.8 Newtron Pharmaceuticals
6.8.1 Newtron Pharmaceuticals Company Information
6.8.2 Newtron Pharmaceuticals Description and Business Overview
6.8.3 Newtron Pharmaceuticals Brompheniramine Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Newtron Pharmaceuticals Brompheniramine Product Portfolio
6.8.5 Newtron Pharmaceuticals Recent Developments/Updates
6.9 Nexgen Pharma
6.9.1 Nexgen Pharma Company Information
6.9.2 Nexgen Pharma Description and Business Overview
6.9.3 Nexgen Pharma Brompheniramine Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Nexgen Pharma Brompheniramine Product Portfolio
6.9.5 Nexgen Pharma Recent Developments/Updates
6.10 Endo International
6.10.1 Endo International Company Information
6.10.2 Endo International Description and Business Overview
6.10.3 Endo International Brompheniramine Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Endo International Brompheniramine Product Portfolio
6.10.5 Endo International Recent Developments/Updates
6.11 Novartis
6.11.1 Novartis Company Information
6.11.2 Novartis Description and Business Overview
6.11.3 Novartis Brompheniramine Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Novartis Brompheniramine Product Portfolio
6.11.5 Novartis Recent Developments/Updates
6.12 Eon Pharma
6.12.1 Eon Pharma Company Information
6.12.2 Eon Pharma Description and Business Overview
6.12.3 Eon Pharma Brompheniramine Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Eon Pharma Brompheniramine Product Portfolio
6.12.5 Eon Pharma Recent Developments/Updates
6.13 Merck
6.13.1 Merck Company Information
6.13.2 Merck Description and Business Overview
6.13.3 Merck Brompheniramine Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Merck Brompheniramine Product Portfolio
6.13.5 Merck Recent Developments/Updates
6.14 Tanta Pharmaceuticals
6.14.1 Tanta Pharmaceuticals Company Information
6.14.2 Tanta Pharmaceuticals Description and Business Overview
6.14.3 Tanta Pharmaceuticals Brompheniramine Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Tanta Pharmaceuticals Brompheniramine Product Portfolio
6.14.5 Tanta Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Brompheniramine Industry Chain Analysis
7.2 Brompheniramine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Brompheniramine Production Mode & Process Analysis
7.4 Brompheniramine Sales and Marketing
7.4.1 Brompheniramine Sales Channels
7.4.2 Brompheniramine Distributors
7.5 Brompheniramine Customer Analysis
8 Brompheniramine Market Dynamics
8.1 Brompheniramine Industry Trends
8.2 Brompheniramine Market Drivers
8.3 Brompheniramine Market Challenges
8.4 Brompheniramine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Pfizer Inc
AMAG Pharmaceuticals
Pai
USL Pharma
Watson Laboratories
TEVA
Ivax Pharmaceuticals
Newtron Pharmaceuticals
Nexgen Pharma
Endo International
Novartis
Eon Pharma
Merck
Tanta Pharmaceuticals
List of Tables
 Table 1. Global Brompheniramine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Brompheniramine Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Brompheniramine Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Brompheniramine Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Brompheniramine Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Brompheniramine Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Brompheniramine Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Brompheniramine Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Brompheniramine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Brompheniramine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Brompheniramine, Product Type & Application
 Table 12. Global Key Manufacturers of Brompheniramine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Brompheniramine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Brompheniramine as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Brompheniramine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Brompheniramine Sales by Region (2020-2025) & (K Units)
 Table 18. Global Brompheniramine Sales Market Share by Region (2020-2025)
 Table 19. Global Brompheniramine Sales by Region (2026-2031) & (K Units)
 Table 20. Global Brompheniramine Sales Market Share by Region (2026-2031)
 Table 21. Global Brompheniramine Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Brompheniramine Revenue Market Share by Region (2020-2025)
 Table 23. Global Brompheniramine Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Brompheniramine Revenue Market Share by Region (2026-2031)
 Table 25. North America Brompheniramine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Brompheniramine Sales by Country (2020-2025) & (K Units)
 Table 27. North America Brompheniramine Sales by Country (2026-2031) & (K Units)
 Table 28. North America Brompheniramine Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Brompheniramine Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Brompheniramine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Brompheniramine Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Brompheniramine Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Brompheniramine Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Brompheniramine Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Brompheniramine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Brompheniramine Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Brompheniramine Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Brompheniramine Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Brompheniramine Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Brompheniramine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Brompheniramine Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Brompheniramine Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Brompheniramine Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Brompheniramine Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Brompheniramine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Brompheniramine Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Brompheniramine Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Brompheniramine Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Brompheniramine Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Brompheniramine Sales (K Units) by Type (2020-2025)
 Table 51. Global Brompheniramine Sales (K Units) by Type (2026-2031)
 Table 52. Global Brompheniramine Sales Market Share by Type (2020-2025)
 Table 53. Global Brompheniramine Sales Market Share by Type (2026-2031)
 Table 54. Global Brompheniramine Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Brompheniramine Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Brompheniramine Revenue Market Share by Type (2020-2025)
 Table 57. Global Brompheniramine Revenue Market Share by Type (2026-2031)
 Table 58. Global Brompheniramine Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Brompheniramine Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Brompheniramine Sales (K Units) by Application (2020-2025)
 Table 61. Global Brompheniramine Sales (K Units) by Application (2026-2031)
 Table 62. Global Brompheniramine Sales Market Share by Application (2020-2025)
 Table 63. Global Brompheniramine Sales Market Share by Application (2026-2031)
 Table 64. Global Brompheniramine Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Brompheniramine Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Brompheniramine Revenue Market Share by Application (2020-2025)
 Table 67. Global Brompheniramine Revenue Market Share by Application (2026-2031)
 Table 68. Global Brompheniramine Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Brompheniramine Price (US$/Unit) by Application (2026-2031)
 Table 70. Pfizer Company Information
 Table 71. Pfizer Description and Business Overview
 Table 72. Pfizer Brompheniramine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Pfizer Brompheniramine Product
 Table 74. Pfizer Recent Developments/Updates
 Table 75. AMAG Pharmaceuticals Company Information
 Table 76. AMAG Pharmaceuticals Description and Business Overview
 Table 77. AMAG Pharmaceuticals Brompheniramine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. AMAG Pharmaceuticals Brompheniramine Product
 Table 79. AMAG Pharmaceuticals Recent Developments/Updates
 Table 80. PAI Company Information
 Table 81. PAI Description and Business Overview
 Table 82. PAI Brompheniramine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. PAI Brompheniramine Product
 Table 84. PAI Recent Developments/Updates
 Table 85. USL Pharma Company Information
 Table 86. USL Pharma Description and Business Overview
 Table 87. USL Pharma Brompheniramine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. USL Pharma Brompheniramine Product
 Table 89. USL Pharma Recent Developments/Updates
 Table 90. Watson Laboratories Company Information
 Table 91. Watson Laboratories Description and Business Overview
 Table 92. Watson Laboratories Brompheniramine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Watson Laboratories Brompheniramine Product
 Table 94. Watson Laboratories Recent Developments/Updates
 Table 95. Teva Company Information
 Table 96. Teva Description and Business Overview
 Table 97. Teva Brompheniramine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Teva Brompheniramine Product
 Table 99. Teva Recent Developments/Updates
 Table 100. Ivax Pharmaceuticals Company Information
 Table 101. Ivax Pharmaceuticals Description and Business Overview
 Table 102. Ivax Pharmaceuticals Brompheniramine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Ivax Pharmaceuticals Brompheniramine Product
 Table 104. Ivax Pharmaceuticals Recent Developments/Updates
 Table 105. Newtron Pharmaceuticals Company Information
 Table 106. Newtron Pharmaceuticals Description and Business Overview
 Table 107. Newtron Pharmaceuticals Brompheniramine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Newtron Pharmaceuticals Brompheniramine Product
 Table 109. Newtron Pharmaceuticals Recent Developments/Updates
 Table 110. Nexgen Pharma Company Information
 Table 111. Nexgen Pharma Description and Business Overview
 Table 112. Nexgen Pharma Brompheniramine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Nexgen Pharma Brompheniramine Product
 Table 114. Nexgen Pharma Recent Developments/Updates
 Table 115. Endo International Company Information
 Table 116. Endo International Description and Business Overview
 Table 117. Endo International Brompheniramine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Endo International Brompheniramine Product
 Table 119. Endo International Recent Developments/Updates
 Table 120. Novartis Company Information
 Table 121. Novartis Description and Business Overview
 Table 122. Novartis Brompheniramine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Novartis Brompheniramine Product
 Table 124. Novartis Recent Developments/Updates
 Table 125. Eon Pharma Company Information
 Table 126. Eon Pharma Description and Business Overview
 Table 127. Eon Pharma Brompheniramine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Eon Pharma Brompheniramine Product
 Table 129. Eon Pharma Recent Developments/Updates
 Table 130. Merck Company Information
 Table 131. Merck Description and Business Overview
 Table 132. Merck Brompheniramine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Merck Brompheniramine Product
 Table 134. Merck Recent Developments/Updates
 Table 135. Tanta Pharmaceuticals Company Information
 Table 136. Tanta Pharmaceuticals Description and Business Overview
 Table 137. Tanta Pharmaceuticals Brompheniramine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Tanta Pharmaceuticals Brompheniramine Product
 Table 139. Tanta Pharmaceuticals Recent Developments/Updates
 Table 140. Key Raw Materials Lists
 Table 141. Raw Materials Key Suppliers Lists
 Table 142. Brompheniramine Distributors List
 Table 143. Brompheniramine Customers List
 Table 144. Brompheniramine Market Trends
 Table 145. Brompheniramine Market Drivers
 Table 146. Brompheniramine Market Challenges
 Table 147. Brompheniramine Market Restraints
 Table 148. Research Programs/Design for This Report
 Table 149. Key Data Information from Secondary Sources
 Table 150. Key Data Information from Primary Sources
 Table 151. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Brompheniramine
 Figure 2. Global Brompheniramine Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Brompheniramine Market Share by Type: 2024 & 2031
 Figure 4. Oral Solution Product Picture
 Figure 5. Tablet Product Picture
 Figure 6. Global Brompheniramine Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Brompheniramine Market Share by Application: 2024 & 2031
 Figure 8. Hospital
 Figure 9. Drug Store
 Figure 10. Global Brompheniramine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Brompheniramine Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Brompheniramine Sales (2020-2031) & (K Units)
 Figure 13. Global Brompheniramine Average Price (US$/Unit) & (2020-2031)
 Figure 14. Brompheniramine Report Years Considered
 Figure 15. Brompheniramine Sales Share by Manufacturers in 2024
 Figure 16. Global Brompheniramine Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Brompheniramine Players: Market Share by Revenue in Brompheniramine in 2024
 Figure 18. Brompheniramine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Brompheniramine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Brompheniramine Sales Market Share by Country (2020-2031)
 Figure 21. North America Brompheniramine Revenue Market Share by Country (2020-2031)
 Figure 22. United States Brompheniramine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Brompheniramine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Brompheniramine Sales Market Share by Country (2020-2031)
 Figure 25. Europe Brompheniramine Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Brompheniramine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Brompheniramine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Brompheniramine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Brompheniramine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Brompheniramine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Brompheniramine Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Brompheniramine Revenue Market Share by Region (2020-2031)
 Figure 33. China Brompheniramine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Brompheniramine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Brompheniramine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Brompheniramine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Brompheniramine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan Brompheniramine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Indonesia Brompheniramine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Thailand Brompheniramine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Malaysia Brompheniramine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Latin America Brompheniramine Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Brompheniramine Revenue Market Share by Country (2020-2031)
 Figure 44. Mexico Brompheniramine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Brazil Brompheniramine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Argentina Brompheniramine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa Brompheniramine Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Brompheniramine Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey Brompheniramine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Brompheniramine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE Brompheniramine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of Brompheniramine by Type (2020-2031)
 Figure 53. Global Revenue Market Share of Brompheniramine by Type (2020-2031)
 Figure 54. Global Brompheniramine Price (US$/Unit) by Type (2020-2031)
 Figure 55. Global Sales Market Share of Brompheniramine by Application (2020-2031)
 Figure 56. Global Revenue Market Share of Brompheniramine by Application (2020-2031)
 Figure 57. Global Brompheniramine Price (US$/Unit) by Application (2020-2031)
 Figure 58. Brompheniramine Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Triprolidine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Medicine Grade Chlorphenamine Maleate Market Research Report 2025
Dexchlorpheniramine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Diphenhydramine Market Insights Forecast to 2030
Mebhydrolin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Carbinoxamine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
OTC Antihistamine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Antihistamine Loratadine Market Research Report 2024
Global Loratadine Market Insights Forecast to 2030
Global Allergy Treatment Loratadine Market Research Report 2024
Global Brolamfetamine Market Research Report 2025
Global Chlorphenamine Market Research Report 2024
Propantheline Bromide Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Doxylamine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Bromperidol Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Diphenylpyraline Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Antazoline Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Azelastine Market Research Report 2025
Global Hay Fever Drug Market Research Report 2025
Global Olopatadine Nasal Spray Market Insights Forecast to 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions